Charles River Labs (CRL) PT Raised to $260 at Morgan Stanley

July 9, 2026 8:15 AM

Morgan Stanley analyst Kallum Titchmarsh raised the price target on Charles River Labs (NYSE: CRL) to $260.00 (from $220.00) while maintaining a Overweight rating.

No results found